Live Analyst Rating Changes 35395 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Benjamin Rossi
JPM

Benjamin Rossi

J.P. Morgan
Wall Street Analyst
★★★★☆
#344
on 13Foresight · ranked by our own returns
78%
Success Rate
+13.6%
Average Return
21 of 27 calls profitable · +50.2% vs benchmark
S&P 500 (SPY)
📈 Across the calls we could measure, roughly 78% of Benjamin Rossi's ratings turned a profit when each position was held for 1 year — averaging +13.6% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

23 Buy 17 Hold 2 Sell
Benjamin's Stock Coverage 12 ratings · 2026-09-29
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return vs S&P 500 ⓘ
INNV
InnovAge Holding
 Sep 17, 2026 SELL Hold
-6.6% avg upside
12 analysts
$10.00
12.50% Upside
 +15.9% ·
AVAH
Aveanna Healthcare Holdings
 Sep 14, 2026 HOLD Buy
-9.7% avg upside
19 analysts
$15.00
18.11% Upside
 -13.7% ·
SGRY
Surgery Partners
 Sep 14, 2026 HOLD Strong Buy
+64.0% avg upside
18 analysts
$15.00
2.14% Upside
 +1.7% ·
USPH
US Physical Therapy
 Sep 11, 2026 BUY Strong Buy
+8.3% avg upside
12 analysts
$95.00
10.27% Upside
 +9.4% ·
GMRS
GMR Solutions, Inc. Class A
 Sep 11, 2026 BUY Strong Buy
+81.9% avg upside
9 analysts
$16.00
59.73% Upside
 -13.5% ·
CON
Concentra Group Holdings Parent, Inc.
 Sep 10, 2026 BUY Strong Buy
+12.3% avg upside
12 analysts
$43.00
21.52% Upside
 +2.2% ·
PACS
PACS Group Inc
 Sep 08, 2026 BUY Strong Buy
+13.5% avg upside
9 analysts
$58.00
34.70% Upside
 -1.4% ·
UHS
Universal Health
 Sep 03, 2026 HOLD Buy
+8.2% avg upside
22 analysts
$200.00
12.76% Upside
 +4.9% ·
THC
Tenet Healthcare
 Sep 01, 2026 BUY Strong Buy
-6.0% avg upside
29 analysts
$315.00
22.19% Upside
 -3.0% ·
HCA
HCA Healthcare
 Aug 24, 2026 HOLD Strong Buy
-6.3% avg upside
37 analysts
$425.00
1.78% Downside
 +1.0% ·
LMRI
Lumexa Imaging Holdings, Inc.
 Aug 10, 2026 BUY Strong Buy
+88.2% avg upside
9 analysts
$18.00
77.37% Upside
 -13.0% ·
ARDT
Ardent Health Partners, Inc.
 Nov 24, 2025 HOLD Buy
+31.0% avg upside
17 analysts
$12.00
14.64% Upside
 +18.7% ·
🔒 7 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Benjamin Rossi — Frequently Asked Questions
How accurate are Benjamin Rossi's stock ratings?
Based on the calls 13Foresight could measure, about 78% of Benjamin's ratings were profitable over a one-year hold, with an average return of +13.7% per rating, or +50.3% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.
How is Benjamin ranked on 13Foresight?
Benjamin Rossi is currently ranked #344 with a 4-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Benjamin cover?
Benjamin most recently has ratings on INNV, AVAH, SGRY, USPH, GMRS, CON, PACS, UHS, THC, HCA, LMRI, ARDT. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.